IMUNOMODULADORES - DARATUMUMAB - 2º SEMESTRE
Buyer: Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
Awarded to JANSSEN CILAG FARMACEUTICA, LDA. Estimated value: €458,281.
€458,281
Estimated value
1
Lots
1
Bids received
Description
IMUNOMODULADORES - DARATUMUMAB - 2º SEMESTRE
Award criteria
- Price — 100%
Awards
| Awarded to | Amount | Date |
|---|---|---|
| JANSSEN CILAG FARMACEUTICA, LDA | — | 15 April 2025 |
Official publications
- TED · 00796933-2025 · 2 December 2025
- OJS · 232/2025 · 2 December 2025
Other tenders from Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
- SUBSTITUTOS ENZIMATICOS - ANTITRIPSINA ALFA - 1
- ANTIANDROGENIOS - APALUTAMIDA - 3 MESES
- ANTI-HEMORRÁGICOS
- IMUNOMODULADORES - RIBOCICLIB - 1º SEMESTRE
- IMUNOGLOBULINAS E SOROS - 1º SEMESTRE
- IMUNOMODULADORES - RIBOCICLIB - 1º SEMESTRE
- IMUNOMODULADORES - PEMBROLIZUMAB - 1 MÊS
- MEDICAMENTOS FIBROSE QUISTICA
- ANTIVIRICOS-BICTEGRAVIR+EMTRICITABINA+TENOFOVIR ALAFENAMIDA 2º SEMESTR
- ANTIANDROGENIOS - APALUTAMIDA - 2º SEMESTRE
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €458,281.
- Who is the buyer of this tender?
- The contracting authority is Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) (European Union).
- How can I bid for public tenders in the European Union?
- Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.
Create a free account and receive new public tenders published in the European Union that match your business, every day.